Collection 專利 [0/39] 期刊論文 [31/31] Siblings 伍素瑩 [53/74] 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 謝興邦 [180/261] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳新(2002-2015) [53/68] 陳炯東 [184/268] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:6(8.57%) 含全文筆數:31(44.29%) 文件下載次數統計 下載大於0次:31(100.00%) 下載大於100次:31(100.00%) 檔案下載總次數:26934(0.46%) 最後更新時間: 2025-05-02 06:55 Top Upload Loading... Top Download Loading... Recent Submissions 增加細胞吞噬作用之方法 Proline derivatives for use to trea... Proline derivatives Proline derivatives 프롤린 유도체 脯氨酸衍生物 Benzimidazole compounds and use the... 脯氨酸衍生物 Benzimidazole compounds and use the... 苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 70. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2024-01-14	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	SG11202101274X/2024-01-14
2023-06-01	增加細胞吞噬作用之方法	TWI804339/2023-06-01
2023-03-03	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	IN424040/2023-03-03
2023-01-27	苯並咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	HK40053325/2023-01-27
2023-01-26	苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	J/006659/2023-01-26
2023-01-24	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	CA3109623/2023-01-24
2022-08-23	苯并咪唑化合物及其在制备治疗阿兹海默症或亨丁顿氏症的药物中的用途	CN113613652/2022-08-23
2022-08	Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels	Journal of Microbiology, Immunology, and Infection. 2022 Aug;55(4):598-610.
2022-05-31	벤즈이미다졸 화합물 및 알츠하이머 질환 또는 헌팅톤병을 치료하기 위한 그의 용도	KR 10-2405760/2022-05-31
2022-03-14	ベンズイミダゾール化合物,及びアルツハイマー病又はハンチントン病の治療のためのその使用	JP7035275/2022-03-14
2021-11-11	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	AU2019333295/2021-11-11
2021-01-01	苯并咪唑化合物及其用於治療阿茲海默症或亨丁頓氏症之用途	TWI715156/2021-01-01
2020-12	Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
2020-03-10	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	US10584120/2020-03-10
2019-12	A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses	Antiviral Research. 2019 Dec;172:Article number 104636.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2019-03-20	Proline derivatives	EP2507232/2019-03-20
2018-09	Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication	Journal of Virological Methods. 2018 Sep;259:10-17.
2017-12	Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels	Journal of Cellular Physiology. 2017 Dec;232(12):3409-3421.
2017-10-24	Proline derivatives for use to treat hepatitis c infection	CA2781140/2017-10-24
2017-08-10	프롤린 유도체	KR10-1768946/2017-08-10
2017-06	Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments	Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2016-07-21	Proline derivatives	AU2010325980/2016-07-21
2016-07	In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71	Journal of Antimicrobial Chemotherapy. 2016 Jul;71(7):1922-1932.

Showing items 1-25 of 70. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page